Доступ предоставлен для: Guest
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции
Critical Reviews™ in Biomedical Engineering
SJR: 0.207 SNIP: 0.376 CiteScore™: 0.79

ISSN Печать: 0278-940X
ISSN Онлайн: 1943-619X

Выпуски:
Том 47, 2019 Том 46, 2018 Том 45, 2017 Том 44, 2016 Том 43, 2015 Том 42, 2014 Том 41, 2013 Том 40, 2012 Том 39, 2011 Том 38, 2010 Том 37, 2009 Том 36, 2008 Том 35, 2007 Том 34, 2006 Том 33, 2005 Том 32, 2004 Том 31, 2003 Том 30, 2002 Том 29, 2001 Том 28, 2000 Том 27, 1999 Том 26, 1998 Том 25, 1997 Том 24, 1996 Том 23, 1995

Critical Reviews™ in Biomedical Engineering

DOI: 10.1615/CritRevBiomedEng.v37.i4-5.30
pages 355-375

Retinal Pigment Epithelium Differentiation of Stem Cells: Current Status and Challenges

Basak E. Uygun
Center For Engineering in Medicine, Shriners Hospital for Children, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
Nripen Sharma
Epigeneres
Martin Yarmush
Center For Engineering in Medicine, Shriners Hospital for Children, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; and Department of Biomedical Engineering, Rutgers University, Piscataway, NJ, USA

Краткое описание

Degeneration and loss of retinal pigment epithelium (RPE) is the cause of a number of degenerative retinal diseases, including age-related macular degeneration (AMD), retinitis pigmentosa, and diabetic retinopathy, leading to blindness that affects three million Americans as of now. Transplantation of RPE aims to restore retinal structure and the interaction between the RPE and photoreceptors, which is fundamental to sight. Although a significant amount of progress has been made in the past 20 years in autologous RPE transplantation, sources for RPE cells are limited. Recent advances in stem cell culture and differentiation techniques have allowed the generation of RPE cells from pluripotent stem cells. In this review, we discuss strategies for generating functional RPE cells from human embryonic stem cells and induced pluripotent stem cells, and summarize transplantation studies of these derived RPEs. We conclude with challenges in cell-replacement therapies using human embryonic and induced pluripotent stem cell-derived RPEs.


Articles with similar content:

Potential Role of Induced Pluripotent Stem Cells as Regenerative Medicine in Retinal Cell Damage
Journal of Environmental Pathology, Toxicology and Oncology, Vol.37, 2018, issue 4
Yi-Ran Pan, Ying-Jian Sun, Bin Fan, Guang-Yu Li
Prostate Cancer and Parasitism of the Bone Hematopoietic Stem Cell Niche
Critical Reviews™ in Eukaryotic Gene Expression, Vol.22, 2012, issue 2
Kenneth J. Pienta, Chunyan Yu, Yusuke Shiozawa, Evan T. Keller, Laurie K. McCauley, Russell S. Taichman
Characteristics and Tissue Regeneration Properties of Gingiva-Derived Mesenchymal Stem Cells
Critical Reviews™ in Eukaryotic Gene Expression, Vol.25, 2015, issue 2
Dehua Li, Zhengze Guo, Zhang Wu, Lei Qin, Ningbo Zhao
Functional Properties of Human Embryonic Stem Cell−Derived Cardiomyocytes
Critical Reviews™ in Eukaryotic Gene Expression, Vol.20, 2010, issue 1
Naama Zeevi-Levin, Ofer Binah, Joseph Itskovitz-Eldor
Bone Tissue Engineering: Recent Advances and Challenges
Critical Reviews™ in Biomedical Engineering, Vol.40, 2012, issue 5
Syam P. Nukavarapu, Cato T. Laurencin, Ami R. Amini